Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ALX ONCOLOGY HOLDINGS INC (ALXO)
|
Add to portfolio |
|
|
|
| Price: |
$20.82
| | Metrics |
| OS: |
41.2
|
M
| |
|
|
| Market cap: |
$857
|
M
| |
|
|
|
Net cash:
|
$215
|
M
| |
$5.22
|
per share
|
|
EV:
|
$642
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($138)
|
M
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.0 | 98.4 | 0.0 | 60.2 | 1.2 | 4.8 | 2.1 |
| Revenue growth | | 63.5% | -100.0% | | -75.4% | 132.0% | |
| Cost of goods sold | 0.0 | 127.4 | -88.3 | 83.6 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | -29.0 | 88.3 | -23.4 | 1.2 | 4.8 | 2.1 |
| Gross margin | | -29.5% | | -38.9% | 100.0% | 100.0% | 100.0% |
| Research and development | 98.4 | | 60.2 | | 29.0 | 16.3 | 11.3 |
| General and administrative | 29.0 | 29.0 | 23.4 | 23.4 | 14.8 | 3.3 | 2.6 |
| EBIT | -127.4 | -127.4 | -78.8 | -83.6 | -43.7 | -19.2 | -13.7 |
| EBIT margin | | -129.5% | | -138.9% | -3694.0% | -400.0% | -662.0% |
| Pre-tax income | -123.4 | -123.4 | -83.5 | -83.5 | -45.5 | -19.2 | -13.7 |
| Income taxes | 0.1 | 0.1 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 |
| Tax rate | | | 0.0% | 0.0% | | | |
| Net income | -123.5 | -123.5 | -83.5 | -83.5 | -50.9 | -23.3 | -17.4 |
| Net margin | | -125.5% | | -138.7% | -4309.8% | -485.2% | -841.9% |
| |
| Diluted EPS | ($3.03) | ($3.03) | ($2.07) | ($2.07) | ($2.76) | ($7.56) | ($6.33) |
| Shares outstanding (diluted) | 40.7 | 40.8 | 40.3 | 40.3 | 18.5 | 3.1 | 2.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|